Angelica Toro Cora (Angelica Toro Coro)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Chronic Myeloid Leukemia

Top Venues

Circulation research

This page only lists publications with an associated author ORCID identifier.

Publications

Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)
Sultan Tousif, Anand Prakash Singh, Prachi Umbarkar, Cristi Galindo, Nicholas D Wheeler, Angelica Toro Cora, Qinkun Zhang, Sumanth D Prabhu, Hind Lal
Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation. Circulation research 132 (3) (2023)